Electroencephelographs (EEG) Pipeline Insight and Competitive Landscape, 2020

Publisher Name :
Date: 17-Sep-2020
No. of pages: 90
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's, "Electroencephelographs (EEG) - Pipeline Insight and Competitive Landscape, 2020," report provides comprehensive insights about 20+ companies and 20+ pipeline devices in Electroencephelographs pipeline landscape. Increased incidence of disorders like Alzheimer's disease, epilepsy, Dementia, Multiple Sclerosis, Parkinson's disease, and stroke around the world has been crucial to elevate the use of electroencephalography (EEG) products. Growing prevalence of neurological diseases and increasing awareness about these are significant contributing factors to advancement. Hence, the market is expected to growth in the coming years. The industries invest in R&D to upgrade existing products and create new ones to satisfy the rising demand for specialized equipment, which is the major reason for an extensive pipeline in this segment. This report provides a detailed study of the emerging Electroencephelographs devices along with competitive landscape to help better understand the emerging Electroencephelographs devices.

Geography Covered

- Global coverage

Electroencephelographs Overview

Electroencephelographs: Understanding

An electroencephalogram (EEG) is a noninvasive test that records electrical patterns in your brain. The test is used to help diagnose conditions such as seizures, epilepsy, head injuries, dizziness, headaches, brain tumors and sleeping problems. It can also be used to confirm brain death.

How does an EEG work?

The billions of nerve cells in your brain produce very small electrical signals that form patterns called brain waves. During an EEG, small electrodes and wires are attached to your head. The electrodes detect your brain waves and the EEG machine amplifies the signals and records them in a wave pattern on graph paper or a computer screen.

Electroencephelographs Devices Competitive Assessment

This segment of the Electroencephelographs report encloses its detailed analysis of various pipeline devices which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths and estimated approval dates and the latest news and press releases. The report also provides list of major players involved in the pipeline product development.

- Product Type

Electroencephelographs can divided based on Types - Standalone devices and Portable devices- both are covered in this report.

- Product Channels

Electroencephelographs can be divided based on Channels - 8-channel EEG, 21-channel EEG, 25 channel EEG, 32-channel EEG, 40-channel EEG, Multi-channel EEG.

- Major Players in Electroencephelographs

There are approx. 20+ key companies which are developing the products for Electroencephelographs.

- Cerora Borealis: Cerora

The Cerora Borealis medical device platform is subject to FDA review and designed to measure and record brainwave activity (EEG) as well as other biosensor data, including cognitive data and voice-based data streams. The platform provides state of the art, mobile and versatile multimodal biosensor data. The first release is intended as an adjunct to standard clinical practice to aid in the evaluation of subject's medical or psychological state. Cerora's next generation devices are intended to aid in the diagnosis and management of various brain disorders, injuries, and diseases. The first release of Borealis is estimated to ship into US markets in 2021 at the earliest.

- Circaid EEG: Circadian Therapeutics

Circaid EEG is being developed by Circadian Therapeutics. Its proof of concept study has already being done and prototype dev phase is ongoing. In a controlled clinical evaluation, data obtained using Circaid EEG® correlate highly with those derived from traditional PSG recording equipment. Work continues towards CE marking and US 510(k) approval.

Further product details are provided in the report……..

Electroencephelographs (EEG) Competitive Benchmarking

This segment of the reports provides analysis of the pipeline report to give a clear understanding of the comparative analysis.

The analysis is based on

- Brand Positioning of Leading companies

- Application

- Industry Collaborations

Electroencephelographs (EEG): Commercialization Activity

This segment of the report provides a detailed list of any commercial activity in the field of EEG devices ranging from collaboration, mergers and acquisition, recent breakthrough among others.

Development Activities

- In June 2020 a study investigating EEG microstate dynamics in schizophrenia was the first research on the temporal structure of the four canonical EEG microstates of schizophrenic patient siblings. Results indicate that a possible endophenotype for schizophrenia is the dynamics of resting-state EEG microstats, specifically classes C and D.

- In April 2020, Marking a major milestone on the path to meeting the objectives of the NIH BRAIN initiative, researchers developed advanced high-density electroencephalography (EEG) as the future paradigm for dynamic functional neuroimaging. The study also marks one of the first times high-density EEG has been used to study epileptic seizures. The more powerful imaging technology, packing more than double the electrodes generally used in a clinical setting, is now available to patients treated at the Mayo Clinic.

Further commercial activities are provided in the report……..

Electroencephelographs (EEG): Reimbursement

- US

FDA approval alone is not a basis for coverage. Electroencephalographic (EEG) monitoring and video recording is a procedure and therefore is not regulated by the FDA. Medicare does not have a National Coverage Determination (NCD) for electroencephalographic (EEG) monitoring and video recording. Local Coverage Determinations (LCDs) exist.

Further information is provided in the report……..

Report Highlights

- Extensive coverage of the Electroencephelographs under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Electroencephelographs and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry

- The report consists of in depth analysis of pipeline products based on various parameters

Electroencephelographs Report Insights

- Electroencephelographs - Pipeline Analysis

- Electroencephelographs - Unmet Need

- Electroencephelographs - Market Dynamics

- Electroencephelographs - Future Perspectives and Conclusion

- Electroencephelographs - Analyst Views

Key Questions

- What are significant companies in this segment, their information, analysis, and insights to improve R&D strategies?

- How to identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage?

- What are important and diverse types of Electroencephelographs under development?

- What are market-entry and market expansion strategies in Electroencephelographs?

- What are some of the mergers and acquisitions and to identify major players with the most promising pipeline?

- What is in-depth analysis of the product's current stage of development, territory and estimated launch date?

Key Players

- AAT Medical Ltd

- Advanced Medical Electronics Corp

- Advanced neurometrics inc.

- Belluscura Limited

- BioSignal Analytics Inc

- Bio-Signal Group Corp.

- Bittium Biosignals Ltd

- BrainCare OY'

- BrainScope Company Inc

- Cerora Inc

- Circadian Therapeutics

- Cognionics, Inc.

- Cogwear LLC

- Compumedics Ltd

- Electrical Geodesics Inc

Electroencephelographs (EEG) Pipeline Insight and Competitive Landscape, 2020

Table of Contents

1. Key Insights
2. Electroencephelographs: Snapshot
3. Electroencephelographs
3.1. Product Overview
3.2. Regulatory Approvals based on Class
3.3. Indications
3.4. Mechanism
4. Electroencephelographs: Competitive Assessment
4.1. Assessment by Product Channels
4.2. Assessment by Product Type
4.3. Assessment by Application
4.3.1. Parkinson's disease
4.3.2. Epilepsy
4.3.3. Alzheimer's Disease
4.3.4. Dementia
4.3.5. Multiple Sclerosis
4.4. Assessment by Company
4.4.1. Cerora
4.4.1.1. Cerora Borealis: Cerora
4.4.1.1.1. Product Information
4.4.1.1.2. Research and Development
4.4.1.1.3. Patent Details
4.4.1.1.4. Regulatory Milestone

4.4.2. Circadian Therapeutics
4.4.2.1. Circaid EEG: Circadian Therapeutics
4.4.2.1.1. Product Information
4.4.2.1.2. Research and Development
4.4.2.1.3. Patent Details
4.4.2.1.4. Regulatory Milestone

*More Companies and products would be added in the final report
5. Electroencephelographs: Competitive Benchmarking : By Company
5.1. Brand Positioning of Leading companies
5.2. Analysis based on Application
5.3. Analysis based on Industry Collaborations
6. Electroencephelographs - Commercialization Activity
6.1. Collaboration
6.2. Licensing
6.3. Merger and Acquisition
6.4. Recent Breakthroughs
6.5. Literature Studies
6.6. KOL Views
7. Electroencephelographs: Regulatory
7.1. US
7.2. Europe
7.3. Japan
8. Electroencephelographs: Reimbursement
8.1. Case Study - US
8.2. Case Study - Europe
8.3. Case Study -Japan
9. Electroencephelographs : Market Dynamics
9.1. Unmet Needs
9.2. Market Drivers
9.3. Market Barriers
10. DelveInsight's Analytical Perspective
10.1. PEST Analysis
10.2. Future Growth Perspectives
11. Conclusion
12. Appendix
12.1. Research Methodology
12.1.1. Coverage
12.1.2. Secondary Research
13. Bibliography
14. DelveInsight Capabilities
15. Disclaimer
16. About DelveInsight

List of Tables

Table 1 Total Pipeline Products
Table 3 Pipeline Products by Technology
Table 4 Pipeline Products by Type
Table 6 List of Companies
Table 7 Cerora Pipeline Products & Ongoing Clinical Trials Overview
Table 8 Cerora Borealis - Product Status
Table 9 Cerora Borealis - Product Description
Table 10 Circadian Therapeutics Pipeline Products & Ongoing Clinical Trials Overview
Table 11 Circaid EEG - Product Status
Table 12 Circaid EEG - Product Description

List of Figures

Figure 1 List of Pipeline Products
Figure 2 Ongoing Clinical Trial
Figure 3 Ongoing Clinical Trial Pipeline Products by Technology
Figure 4 Ongoing Clinical Trial Pipeline Products by Type
  • COVID-19 World Indomethacin Market Research Report (by Product Type, End-User / Application and Regions / Countries)
    Published: 22-Oct-2020        Price: US 2800 Onwards        Pages: 108
    Summary This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. The report includes as follows: The report provides current data, historical overview and future forecast. The report includes an in-depth analysis of the Global market for Indomethacin , covering Global total and......
  • Global and China Topiramate Market Insights, Forecast to 2026
    Published: 22-Oct-2020        Price: US 3900 Onwards        Pages: 131
    Topiramate market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Topiramate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Topiramate market is segmented into - 0.98......
  • Global and Japan Lincomycin Hydrochloride Market Insights, Forecast to 2026
    Published: 22-Oct-2020        Price: US 3900 Onwards        Pages: 127
    Lincomycin Hydrochloride market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Lincomycin Hydrochloride market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Lincomycin Hydrochlorid......
  • Global and China Pinaverium Bromide Market Insights, Forecast to 2026
    Published: 22-Oct-2020        Price: US 3900 Onwards        Pages: 127
    Pinaverium Bromide market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Pinaverium Bromide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Pinaverium Bromide market is segmen......
  • Global and Japan Tamoxifen Citrate Market Insights, Forecast to 2026
    Published: 22-Oct-2020        Price: US 3900 Onwards        Pages: 133
    Tamoxifen Citrate market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Tamoxifen Citrate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the Tamoxifen Citrate market is segmented......
  • 2020-2029 Report on Global Primary Immunodeficiency Diseases Treatment Market by Player, Region, Type, Application and Sales Channel
    Published: 22-Oct-2020        Price: US 2500 Onwards        Pages: 135
    The global Primary Immunodeficiency Diseases Treatment market was valued at $XX million in 2019, and MAResearch analysts predict the global market size will reach $XX million by the end of 2029, growing at a CAGR of XX% between 2020 and 2029. Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 210 countries and territories around the world and 2 international conveyances. The global impacts of COVID-19 are already starting to be felt, and will signif......
  • 2020-2029 Report on Global Antibody Drug Conjugate Market by Player, Region, Type, Application and Sales Channel
    Published: 22-Oct-2020        Price: US 2500 Onwards        Pages: 135
    The global Antibody Drug Conjugate market was valued at $XX million in 2019, and MAResearch analysts predict the global market size will reach $XX million by the end of 2029, growing at a CAGR of XX% between 2020 and 2029. Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 210 countries and territories around the world and 2 international conveyances. The global impacts of COVID-19 are already starting to be felt, and will significantly affect this ......
  • (Post-pandemic Era) - Global Rotavirus Vaccine Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type
    Published: 21-Oct-2020        Price: US 4860 Onwards        Pages: 89
    Summary This study analysis was given on a worldwide scale, for instance, present and historical Rotavirus Vaccine growth analysis, competitive analysis, and also the growth prospects of the major regions. The report gives an exhaustive investigation of this market at country & regional levels, and provides an analysis of the industry trends in each of the sub-segments, from production, revenue and consumption. A quantitative and qualitative analysis of the main players in related......
  • (Post-pandemic Era) - Global Rotavirus Vaccine Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2026
    Published: 21-Oct-2020        Price: US 3650 Onwards        Pages: 104
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs